Log in to save to my catalogue

Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Morta...

Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Morta...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A716104549

Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report

About this item

Full title

Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report

Publisher

NewsRX LLC

Journal title

Vaccine Weekly, 2022, p.66

Language

English

Publication information

Publisher

NewsRX LLC

More information

Alternative Titles

Full title

Sanofi higher dose flu vaccines preferentially recommended for adults 65+ in CDC Morbidity and Mortality Weekly Report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A716104549

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A716104549

Other Identifiers

ISSN

1074-2921

How to access this item